A metabolite-GWAS (mGWAS) approach to unveil chronic kidney disease progression
Authors:
- 1 June 2017
- journal article
- editorial
- Published by Elsevier in Kidney International
- Vol. 91 (6) , 1274-1276
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney diseaseKidney International, 2017
- Stability of targeted metabolite profiles of urine samples under different storage conditionsMetabolomics, 2016
- Systems biology analysis reveals role of MDM2 in diabetic nephropathyJCI Insight, 2016
- Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarkerScience Translational Medicine, 2015
- An atlas of genetic influences on human blood metabolitesNature Genetics, 2014
- Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney DiseaseJournal of the American Society of Nephrology, 2013
- A systems approach identifies HIPK2 as a key regulator of kidney fibrosisNature Medicine, 2012
- A genome-wide association study of metabolic traits in human urineNature Genetics, 2011
- Genomewide Linkage Analysis to Serum Creatinine, GFR, and Creatinine Clearance in a Community-Based PopulationJournal of the American Society of Nephrology, 2004